Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has announcements × Hematologic Neoplasms × talquetamab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2 Plasma cell 1

Conditions

Hematologic Neoplasms 2 Multiple Myeloma 1

Interventions

talquetamab 2 ivosidenib 1 fedratinib 1 enasidenib 1 Midazolam 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634552 2026-03-17

MonumenTAL-1

Janssen Research & Development, LLC

Phase 2 Recruiting

510 enrolled 1 FDA

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT03399799 2026-03-12

MonumenTAL-1

Janssen Research & Development, LLC

Phase 1 Active not recruiting

279 enrolled 1 FDA

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡